ADVERTISEMENT
Jim CramerScott Mlyn | CNBC(This story is for CNBC Professional subscribers solely). The brand new fast check for Covid-19 from Abbott Laboratories might be the event that sparks a turnaround for the journey trade, CNBC’s Jim Cramer mentioned Thursday.The medical machine firm introduced on Wednesday evening that it acquired an emergency use authorization from the Meals and Drug Administration for a brand new 15-minute check. Abbott’s stock surged on Thursday morning as some Wall Street analysts referred to as the check a “recreation changer.” Cramer mentioned on “Squawk on the Street” that, if not for Fed Chair Jerome Powell’s speech, the check can be the most important markets story of the day.
